Ferozsons Laboratories Limited

PSX-FEROZ
Pakistan Stock Exchange
Healthcare Pharmaceuticals
Global Rank
#28690
Country Rank
#124
Market Cap
56.53 M
Price
1.3
Change (%)
0.80%
Volume
53,736

Ferozsons Laboratories Limited's latest marketcap:

56.53 M

As of 06/27/2025, Ferozsons Laboratories Limited's market capitalization has reached $56.53 M. According to our data, Ferozsons Laboratories Limited is the 28690th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 56.53 M
Revenue (ttm) 63.14 M
Net Income (ttm) 2.62 M
Shares Out 43.47 M
EPS (ttm) 0.06
Forward PE 0.00
Ex-Dividend Date 10/18/2024
Earnings Date 09/01/2025
Market Cap Chart
Data Updated: 06/27/2025

Ferozsons Laboratories Limited's yearly market capitalization.

Ferozsons Laboratories Limited has seen its market value drop from rs17.25 B to rs56.53 M since 2014, representing a total decrease of 99.67% and an annual compound decline rate (CAGR) of 42.04%.
Date Market Cap Change (%) Global Rank
06/27/2025 rs56.53 M 12.41% 28690
12/31/2024 rs14.58 B 51.99% 27784
12/29/2023 rs9.59 B 60.41% 30455
12/30/2022 rs5.98 B -49.34% 31124
12/31/2021 rs11.8 B -1.38% 25787
12/31/2020 rs11.97 B 89.14% 22400
12/31/2019 rs6.33 B 45.27% 23027
12/31/2018 rs4.36 B -29.2% 23446
12/29/2017 rs6.15 B -72.79% 21004
12/30/2016 rs22.61 B -32.33% 12504

Company Profile

About Ferozsons Laboratories Limited

Ferozsons Laboratories Limited, along with its subsidiaries, is a leading pharmaceutical company specializing in the import, manufacturing, and sale of pharmaceutical products and medical devices. The company operates in multiple countries, including Pakistan, Afghanistan, Sri Lanka, the Philippines, Kenya, Myanmar, Kyrgyzstan, Mongolia, and Cambodia.

Product Offerings

The company provides a diverse range of pharmaceutical products across various therapeutic areas, such as:

  • Anti-fungal & anti-viral
  • Antibiotics
  • Cardiometabolic
  • Cough & dermatology
  • Diabetes
  • Gastrointestinal & liver
  • Oncology
  • Orthopedic
  • Urology & nephrology

Medical Devices

Ferozsons also offers advanced medical devices in specialized fields, including:

  • Cardiology
  • G.I. endoscopy
  • Oncology
  • Peripheral vascular disease
  • Urology
  • Women's health

Established in 1954, Ferozsons Laboratories Limited is headquartered in Lahore, Pakistan, and continues to expand its global footprint.

Frequently Asked Questions

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.